Tuhura Biosciences Inc. has amended its existing secured promissory note and loan agreement with the Matthew Nachtrab Revocable Trust. Under the amended terms, the lender extended the loan availability period to December 5, 2025, and provided Tuhura with an additional $1.5 million loan, bringing the total funds advanced to $3.0 million. In connection with the financing, Tuhura issued the lender a warrant to purchase 234,783 shares of common stock at an exercise price of $1.81 per share, with warrants allocated in proportion to amounts borrowed. The warrant will expire two years from the issuance date. No other material changes were made to the original loan agreement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tuhura Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-309853), on December 05, 2025, and is solely responsible for the information contained therein.